Axial Spondyloarthritis Disease Activity Cutoffs at Golimumab Initiation in the French GO-PRACTICE Study: Parallels With the German GO-NICE Study

J Rheumatol. 2020 Dec 1;47(12):1844-1846. doi: 10.3899/jrheum.200172. Epub 2020 Oct 15.

Authors

Philippe Goupille¹, Naoual Harid², René-Marc Flipo³

Affiliations

¹ University of Tours, EA GICC 7501, and Department of Rheumatology, University Hospital of Tours, Tours.
² MSD France, Puteaux; naoual.harid@msd.com.
³ Department of Rheumatology, Roger Salengro University Hospital, Lille, France.

PMID: 33060324
DOI: 10.3899/jrheum.200172

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antirheumatic Agents* / therapeutic use
Humans
Spondylarthritis* / drug therapy

Substances

Antibodies, Monoclonal
Antirheumatic Agents
golimumab